Status:
UNKNOWN
Role of Echocardiography in Pulmonary Embolism
Lead Sponsor:
Assiut University
Conditions:
Pulmonary Embolism
Eligibility:
All Genders
18-70 years
Brief Summary
1. To analyze the diagnostic and prognostic value of echocardiographic parameters. 2. Prediction of APE-related 30-day mortality and adverse out comes. 3. The need for rescue thrombolysis in initially...
Detailed Description
Acute pulmonary embolism (APE) is the most serious clinical presentation of venous thromboembolism (VTE). According to registries and hospital discharge databases of unselected patients with Acute pul...
Eligibility Criteria
Inclusion
- Age \>18 and \<70 years.
- Patients with intermediate- risk pulmonary embolism will be
- -hemodynamically stable at admission with systolic blood pressure
- 90 mmHg and without signs of peripheral hypoperfusion.
- \- elevated cardiac biomarkers levels (particularly, a positive cardiac troponin test
Exclusion
- 1- Age \<18 years.
- 2- Patients diagnosed with chronic thromboembolic hypertension.
- 3- Patients with valvular heart diseases.
- 4- Patients with lung cancer.
- 5- Acute massive pulmonary embolism.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04020250
Start Date
August 1 2019
End Date
September 1 2020
Last Update
July 16 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.